<table border="single" frame="box" id="ID_A89C96C2-E491-42FB-AB46-7DFC2E0DD80D" width="266.4" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption id="ID_A7CDF7AA-2430-48FF-B6F6-D36E3DC0476C">Table 2: Dose to body weight range to achieve similar steady-state exposure (AUC<sub>0-24hr</sub>) to unbound oxaprozin in JRA patients relative to 70 kg adult rheumatoid arthritis patients administered oxaprozin 1200 mg QD<sup>1</sup></caption>
<col width="51.539%"></col>
<col width="48.461%"></col>
<tbody>
<tr id="ID_709C3511-5215-452E-8D8C-43B36DC54197"><td align="center" valign="bottom">Dose (mg)</td><td align="center" valign="bottom">Body Weight Range (kg)</td></tr>
<tr id="ID_DA3B6EA8-FCA6-415F-84B9-89B29D05CF51"><td align="center" valign="bottom">600</td><td align="center" valign="bottom">22-31</td></tr>
<tr id="ID_79E7A151-F727-4F01-9D8C-F1B48C9F5DD4"><td align="center" valign="bottom">900</td><td align="center" valign="bottom">32-54</td></tr>
<tr id="ID_7A3FAA5E-B5CB-496D-BB52-8BAAD35C4E94"><td align="center" valign="bottom">1200</td><td align="center" valign="bottom">â‰¥ 55</td></tr>
</tbody>
</table>